Related Experiment Video
Updated: Mar 7, 2026
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Total synthesis of a Streptococcus pneumoniae serotype 12F CPS repeating unit hexasaccharide
Peter H Seeberger1, Claney L Pereira2, Subramanian Govindan3
1Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476 Potsdam, Germany; Department of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195 Berlin, Germany.
Insights
Scientists synthesized a key component of the Streptococcus pneumoniae serotype 12F capsular polysaccharide (CPS) to understand protective epitopes. This synthetic hexasaccharide advances vaccine development by enabling further immunological studies.
Area of Science:
- Microbiology
- Carbohydrate Chemistry
- Immunology
Background:
- * *Streptococcus pneumoniae* is a major global pathogen causing severe diseases.
- * Current vaccines target bacterial capsular polysaccharide (CPS) epitopes, but a deeper understanding of protective epitopes is needed.
- * Defined oligosaccharides from total synthesis are crucial for studying these epitopes.
Purpose of the Study:
- * To synthesize the hexasaccharide repeating unit of *S. pneumoniae* serotype 12F CPS.
- * To develop a synthetic strategy for complex oligosaccharides not present in current vaccines.
- * To provide a tool for further immunological investigations of protective epitopes.
Main Methods:
- * Employed a linear synthesis strategy involving sequential assembly of monosaccharide building blocks.
- * Utilized orthogonal protecting groups to manage branching points in the hexasaccharide structure.
- * Explored and contrasted a convergent [3 + 3] strategy, identifying its limitations.
Main Results:
- * Successfully achieved the total synthesis of the *S. pneumoniae* serotype 12F CPS hexasaccharide repeating unit.
- * Demonstrated the superiority of a linear synthetic approach over a convergent one due to steric hindrance.
- * Prepared a well-defined hexasaccharide for subsequent immunological studies.
Conclusions:
- * The total synthesis of the *S. pneumoniae* serotype 12F CPS hexasaccharide was accomplished.
- * A linear synthetic strategy is effective for constructing complex bacterial oligosaccharides.
- * The synthetic hexasaccharide serves as a foundation for future research into protective immune responses.
Abstract:
The Gram-positive bacterium Streptococcus pneumoniae causes severe disease globally. Vaccines that prevent S. pneumoniae infections induce antibodies against epitopes within the bacterial capsular polysaccharide (CPS). A better immunological understanding of the epitopes that protect from bacterial infection requires defined oligosaccharides obtained by total synthesis. The key to the synthesis of the S. pneumoniae serotype 12F CPS hexasaccharide repeating unit that is not contained in currently used glycoconjugate vaccines is the assembly of the trisaccharide β-D-GalpNAc-(1→4)-[α-D-Glcp-(1→3)]-β-D-ManpNAcA, in which the branching points are equipped with orthogonal protecting groups. A linear approach relying on the sequential assembly of monosaccharide building blocks proved superior to a convergent [3 + 3] strategy that was not successful due to steric constraints. The synthetic hexasaccharide is the starting point for further immunological investigations.
Related Concept Videos
01:28Peptidoglycan Synthesis
01:19Formation of Lipopolysaccharides
01:24Oligosaccharide Assembly
Multiple sugar molecules that may or may...
01:05Proteoglycans
01:26Biosynthesis of Polysaccharides
01:18Outer Layers of the Cell Envelope